22:23:52 EDT Tue 06 Jun 2023
Enter Symbol
or Name

Login ID:

Senseonics to Participate in the Jefferies Healthcare Conference

2023-05-26 07:00 ET - News Release

Company Website: http://www.senseonics.com/
GERMANTOWN, Md. -- (Business Wire)

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Jefferies Healthcare Conference in New York, NY.

Management is scheduled to present on Friday, June 9, 2023, from 9:30am to 9:55am ET. Interested parties may access a live and recorded webcast of the presentation on the “Investor Relations” section of the company’s website at www.senseonics.com.

About Senseonics

Senseonics Holdings, Inc. (“Senseonics”) is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the global diabetes community with differentiated, long-term implantable glucose management technology. Senseonics' CGM systems, Eversense®, Eversense® XL and Eversense® E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every 5 minutes to a mobile app on the user's smartphone.


Senseonics Investor Relations Contact:
Philip Taylor
Investor Relations

Source: Senseonics Holdings, Inc.

© 2023 Canjex Publishing Ltd. All rights reserved.